EVEREST MED.LTD DL-0001 Cash Flow-to-Debt Ratio
EVEREST MED.LTD DL-0001 cash flow-to-debt ratio. EVEREST MED.LTD DL-0001 (6HN) has a Cash Flow-to-Debt Ratio of -0.06x as of December 2025, meaning its operating cash flow of €-92.56 Million could theoretically repay 0% of its total liabilities (€1.53 Billion) in one year. See 6HN financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of EVEREST MED.LTD DL-0001 (2021–2025)
Cash flow-to-debt ratio of EVEREST MED.LTD DL-0001 from 2021 to 2025. Historical debt coverage capacity for EVEREST MED.LTD DL-0001 across 5 annual periods. Also explore EVEREST MED.LTD DL-0001 (6HN) equity growth momentum to track the company's year-over-year net asset growth rate.
EVEREST MED.LTD DL-0001 Cash Flow-to-Debt Ratio by Year (2021–2025)
EVEREST MED.LTD DL-0001 cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for EVEREST MED.LTD DL-0001. For the full cash flow conversion analysis, see cash flow conversion of EVEREST MED.LTD DL-0001.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.06x | €-92.56 Million | €1.53 Billion | ▲ +92.1% |
| 2024 | -0.77x | €-679.51 Million | €886.05 Million | ▲ +19.8% |
| 2023 | -0.96x | €-769.19 Million | €804.10 Million | ▲ +20.5% |
| 2022 | -1.20x | €-1.16 Billion | €960.25 Million | ▼ -24.3% |
| 2021 | -0.97x | €-729.94 Million | €753.83 Million | — |